XBiotech Inc.

NASDAQ:XBIT

Biotechnology

Healthcare
$1.68 -0.84%

-$0.02 today

Market cap
$51.22M
Beta
0.84
P/E (TTM)
-1.8
EPS (TTM)
-$1.32
52W Low $2.09High $3.61

Volume 0.05M

Average 0.03M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$39.92M

FY 2025 · Annual

Investing Cash Flow

-$289,000.00

FY 2025 · Annual

Financing Cash Flow

-$10.25M

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(17.41M)(32.9M)(24.56M)(38.53M)(45.54M)
Depreciation & Amortization2.65M2.61M1.74M1.75M1.69M
Deferred Income Tax00005K
Stock-Based Compensation4.46M5.06M3.26M1.75M3.62M
Change in Working Capital79.75M7.6M2.72M(1.46M)3.64M
Accounts Receivables1.73M7.34M829K77K574K
Inventory00000
Accounts Payables(514K)357K91K(364K)(688K)
Other Working Capital78.53M(97K)1.8M(1.17M)3.75M
Other Non-Cash Items4.46M2.8M(1.89M)5.53M(3.33M)
Operating Cash Flow69.45M(14.82M)(18.73M)(30.96M)(39.92M)
Capital Expenditures(3.53M)(585K)(362K)(1.3M)(289K)
Acquisitions (Net)00000
Purchases of Investments0(63.31M)000
Sales of Investments00000
Other Investing Activities0061.86M00
Investing Cash Flow(3.53M)(63.89M)61.5M(1.3M)(289K)
Debt Repayment00010.25M(10.25M)
Common Stock Issued005K00
Common Stock Repurchased00000
Dividends Paid(75M)0000
Other Financing Activities8M0(14K)200K0
Financing Cash Flow(67.01M)0(9K)10.45M(10.25M)
Effect of Forex Changes705K(961K)(46K)(5.53M)3.33M
Net Change in Cash(383K)(79.68M)42.72M(27.35M)(47.13M)
Free Cash Flow65.92M(15.41M)(19.09M)(32.27M)(40.21M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$45.5M
+ D&A$1.7M
+ Stock-Based Comp$3.6M
+ Deferred Tax$5.0K
+ Working Capital$3.6M
- Other Non-Cash-$3.3M
= Operating Cash Flow-$39.9M
- Capex-$289.0K
= Free Cash Flow-$40.2M

Analysis

FY2025 free cash flow is -$40.2M. FCF conversion is 88.3% of net income. Operating cash flow was -$39.9M, with capex of -$289.0K. The largest bridge item is Working Capital at $3.6M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 13, 2026
10-QQuarterly reportNov 12, 2026
4Statement of changes in beneficial ownershipOct 28, 2026
3Initial statement of beneficial ownershipOct 28, 2026
4Statement of changes in beneficial ownershipOct 28, 2026

Does XBIT generate free cash flow?

XBiotech Inc. (XBIT) generated -$40.21M of free cash flow in fiscal 2025.

How much operating cash flow does XBIT produce?

Operating cash flow was -$39.92M, before capital expenditures of $289,000.00.